Scientists trace human blood cells back to ancient single-celled ancestorsScientists have uncovered evidence that human blood and immune cells may have evolved from ancient single-celled organisms nearly 700 milli...
28 May, 2026, 06.37 AM IST
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
27 May, 2026, 12.24 PM IST
Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
26 May, 2026, 04.38 PM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%, according to analystsThis is easy to say, but difficult to actually implement: As an investor, make a distinction between the day-to-day movement of indices and...
22 May, 2026, 10.11 PM IST
Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
20 May, 2026, 02.53 PM IST
For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
20 May, 2026, 02.19 PM IST
From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
18 May, 2026, 06.40 PM IST
These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
14 May, 2026, 11.51 PM IST
Bee, wasp, or hornet nest? Why the wrong guess can quickly turn dangerousIdentifying stinging insect nests is crucial before removal, as bees, wasps, and hornets exhibit different behaviors and defensive reaction...
12 May, 2026, 06.54 PM IST
Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...
06 May, 2026, 01.13 AM IST
Kiran Mazumdar-Shaw picks niece Claire as successor at BioconBiocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...
06 May, 2026, 01.07 AM IST
Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
05 May, 2026, 11.51 AM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
24 Apr, 2026, 10.18 PM IST
Biocon rolls out two biosimilars in US marketBiocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...
07 Apr, 2026, 07.44 PM IST
Veterinary vaccine firms form association for collaboration with policymakersIndia's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have formed the Veterinary Vaccin...
28 Sep, 2025, 11.37 AM IST
Sanofi buys US biopharma group Blueprint in $9.1 billion dealSanofi is set to acquire Blueprint Medicines for $9.1 billion, strengthening its immunology portfolio with the addition of Ayvakit/Ayvakyt,...
02 Jun, 2025, 11.35 AM IST
State-owned BIBCOL set to begin production of Bharat Bio's Covaxin by February 2022The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sande...
28 Jul, 2021, 09.27 AM IST